Pages that link to "Q34060210"
Jump to navigation
Jump to search
The following pages link to Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease. (Q34060210):
Displaying 50 items.
- Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH (Q26742102) (← links)
- Role of Hedgehog Signaling Pathway in NASH (Q26743373) (← links)
- The Immune Landscape in Nonalcoholic Steatohepatitis (Q26747323) (← links)
- The Role of Vitamins in the Pathogenesis of Non-alcoholic Fatty Liver Disease (Q26752762) (← links)
- NKT cell subsets as key participants in liver physiology and pathology (Q26766141) (← links)
- The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease (Q26784452) (← links)
- Innate immune cells in liver inflammation (Q26859951) (← links)
- Natural killer cells in liver disease (Q27025451) (← links)
- Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update (Q27027703) (← links)
- Molecular Pathogenesis of NASH (Q28071265) (← links)
- Immune Imbalances in Non-Alcoholic Fatty Liver Disease: From General Biomarkers and Neutrophils to Interleukin-17 Axis Activation and New Therapeutic Targets (Q28079713) (← links)
- The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis. (Q30382395) (← links)
- Inflammation in nonalcoholic steatohepatitis (Q30453231) (← links)
- Indirect markers of non-alcoholic fatty liver disease: Another piece of the puzzle? (Q33350030) (← links)
- Natural killer T (NKT) cells in autoimmune hepatitis (Q33580295) (← links)
- Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation (Q33755829) (← links)
- Fibrosis-dependent mechanisms of hepatocarcinogenesis (Q33865082) (← links)
- Early life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primates (Q33959776) (← links)
- Fat: a matter of disturbance for the immune system. (Q34200814) (← links)
- Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. (Q34271108) (← links)
- From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. (Q34365079) (← links)
- NAFLD, NASH and liver cancer (Q34374372) (← links)
- Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury (Q34458652) (← links)
- Osteopontin is induced by hedgehog pathway activation and promotes fibrosis progression in nonalcoholic steatohepatitis. (Q34511187) (← links)
- Intrahepatic natural killer T cell populations are increased in human hepatic steatosis (Q34772032) (← links)
- Pro-inflammatory activated Kupffer cells by lipids induce hepatic NKT cells deficiency through activation-induced cell death (Q35061420) (← links)
- Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis (Q35122049) (← links)
- Tumor necrosis factor-inducible gene 6 promotes liver regeneration in mice with acute liver injury. (Q35409945) (← links)
- The split personality of NKT cells in malignancy, autoimmune and allergic disorders (Q35590727) (← links)
- Type II NKT Cells in Inflammation, Autoimmunity, Microbial Immunity, and Cancer (Q35750702) (← links)
- A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease (Q35933771) (← links)
- Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation (Q36084822) (← links)
- Choline Deficiency Causes Colonic Type II Natural Killer T (NKT) Cell Loss and Alleviates Murine Colitis under Type I NKT Cell Deficiency (Q36251478) (← links)
- Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease (Q36402141) (← links)
- Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network. (Q36438251) (← links)
- Natural killer and natural killer T cells in liver fibrosis (Q36553227) (← links)
- Slam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditis (Q36582861) (← links)
- NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease (Q36626940) (← links)
- Hedgehog signaling in cholangiocytes (Q36795740) (← links)
- Liver Injury and the Activation of the Hepatic Myofibroblasts (Q37109402) (← links)
- Innate immunity in alcoholic liver disease (Q37174755) (← links)
- Immunological mechanisms in the pathophysiology of non-alcoholic steatohepatitis (Q37291200) (← links)
- Activation and increase of radio-sensitive CD11b+ recruited Kupffer cells/macrophages in diet-induced steatohepatitis in FGF5 deficient mice (Q37314995) (← links)
- Innate immune activation in obesity (Q37466096) (← links)
- Role of gut microbiota in liver diseases (Q37488165) (← links)
- CEACAM1 loss links inflammation to insulin resistance in obesity and non-alcoholic steatohepatitis (NASH). (Q37624585) (← links)
- Alcoholic, Nonalcoholic, and Toxicant-Associated Steatohepatitis: Mechanistic Similarities and Differences (Q37635136) (← links)
- Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. (Q37665974) (← links)
- Pathophysiology of NASH: perspectives for a targeted treatment (Q37699476) (← links)
- Roles of liver innate immune cells in nonalcoholic fatty liver disease (Q37793003) (← links)